Related Experiment Video
Updated: Mar 12, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study
Cesare Cuspidi1,2, Carla Sala3, Anna Casati1
1Department of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy.
Insights
Subclinical cardiac damage, like left ventricular hypertrophy, indicates higher cardiovascular risk. The PAMELA study assessed these changes and their prognostic impact in the general population.
Area of Science:
- Cardiology
- Cardiovascular Research
- Clinical Epidemiology
Background:
- Subclinical cardiovascular structural changes reflect cumulative damage from risk factors.
- These alterations represent an intermediate stage between risk factor exposure and clinical events.
- Such damage is a recognized marker of increased cardiovascular risk in various populations.
Purpose of the Study:
- To assess normal values and prognostic significance of ambulatory and home blood pressure.
- To investigate the prevalence, correlates, and prognostic value of subclinical cardiac alterations.
- To review findings on cardiac abnormal phenotypes from the PAMELA study.
Main Methods:
- The Pressioni Monitorate e Loro Associazioni (PAMELA) study enrolled a representative Northern Italian general population sample.
- Data collection included ambulatory blood pressure monitoring, home blood pressure monitoring, electrocardiography (ECG), and echocardiography (ECHO).
- Analysis focused on clinical aspects and prognostic significance of cardiac abnormal phenotypes.
Main Results:
- The PAMELA study extensively investigated subclinical cardiac alterations.
- Findings cover the prevalence and clinical correlates of phenotypes like left ventricular hypertrophy.
- The prognostic value of these cardiac abnormalities was also extensively examined.
Conclusions:
- Subclinical cardiac structural changes are significant indicators of cardiovascular risk.
- The PAMELA study provides valuable insights into blood pressure monitoring and cardiac health.
- Understanding these phenotypes is crucial for risk stratification in the general population.
Abstract:
Because subclinical alterations in cardiovascular structure reflect cumulative damage induced by risk factors and represent an intermediate stage between risk factor exposure and cardiovascular events, this damage is regarded as a marker of increased cardiovascular risk in different clinical settings, including the general population. The Pressioni Monitorate e Loro Associazioni (PAMELA) is an originally designed research study aimed at assessing the normal values and prognostic significance of ambulatory and home blood pressure in a representative sample of the Northern Italian general population. Because the study protocol included the collection of electrocardiographic (ECG) and echocardiographic (ECHO) data, the prevalence and clinical correlates, as well as the prognostic value of subclinical cardiac alterations, have been extensively investigated. This article is a review of the findings of the PAMELA study regarding the clinical aspects and prognostic significance of cardiac abnormal phenotypes such as left ventricular hypertrophy, left atrial dilatation and aortic root dilation.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Acute Coronary Syndrome III: Diagnostic Studies

